Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -2017/18 group results

May 11 (Reuters)- 
          Takara Bio Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales           32.31           29.38          36.80         17.76    
               (+10.0 pct)     (-1.2 pct)     (+13.9 pct)   (+25.7 pct) 
  Operating        3.56            3.20           5.00          2.50    
               (+11.0 pct)     (+20.1 pct)    (+40.6 pct)  (+263.1 pct) 
  Recurring        3.86            3.58           5.20          2.56    
               (+7.9 pct)      (+8.4 pct)     (+34.6 pct)  (+233.8 pct) 
  Net
  Net              2.34            1.35           3.10          1.65    
               (+72.6 pct)     (+1.4 pct)     (+32.8 pct)  (+444.1 pct) 
  EPS           19.39 yen       11.24 yen      25.74 yen     13.68 yen  
  Ann Div       4.50 yen        4.00 yen       6.00 yen                 
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div       4.50 yen        4.00 yen       6.00 yen                 
  
  NOTE - Takara Bio Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news